Moderna reaches "landmark moment" in Melanoma vaccine trial
CBS News medical correspondent Dr. Céline Gounder joins "The Daily Report" to discuss what Moderna's melanoma vaccine breakthrough could mean as clinical trials continue.
Automated coverage analysis
Generated automatically from the coverage listed on this page. CurrentWire adds no editorial claims.
Coverage
1 publication is covering this story.
How CurrentWire compiled this story
CBS News (www.cbsnews.com), a Tier B publisher, filed this report on .
Signal breakdown
CurrentWire ranked this story 59.7 of 100 in the snapshot this page was rendered from.
- Freshness
- 30.2 of 35
- Source authority
- 14 of 20
- Coverage breadth
- 4 of 20
- Geographic relevance
- 3.5 of 10
- Story prominence
- 8 of 10
- Velocity
- 0 of 5
Strongest signal: freshness, 30.2 of 35. How each signal is calculated.
Filed under Health · International · News.
CurrentWire is a news discovery platform. This page summarizes and links to original reporting; full articles, imagery and copyright remain with the publishers listed above.